ARTICLE | Clinical News
AKC Phase II mucositis data
February 20, 2001 8:00 AM UTC
Access Pharmaceuticals (AKC) said that preliminary interim data from 23 mucositis patients in a Phase II study showed no significant difference between the company's OraRinse amlexanox and its mucoadh...